Cardiovascular, Renal, Metabolic, Liver and Obesity Conference

Cardiovascular, Renal, Metabolic, Liver and Obesity Conference Empowering Family Physicians in Cardiometabolic, Liver and Obesity Management

Initiated by Kenes Group.

Cardiac disease, chronic kidney and liver disease and metabolic derangements like type 2 diabetes (T2DM) and their risk factors share etiologies and pathophysiologic mechanisms. These novel insights and their therapeutic implications have been recognized and adopted by cardiology, nephrology and endocrinology alike. Yet a need exists for a multidisciplinary scientific platform that unites all interested parties and serves as a unique gathering, devoting time to in-depth Cardiovascular, Renal, Liver, Metabolic and Obesity discussions. This conference will continue to spotlight the pivotal role of family physicians in the integrated management of cardiometabolic, renal, liver and obesity syndromes (CaReMeLO), with enhanced focus on the latest GLP-1 RA therapies such as Tirzepatide and Semaglutide 2,4 mg.

Join our interactive live Meet the Expert Session: "CaReMe Syndrome: Early Recognition and Diagnoses"📅 Wednesday, 15th O...
14/10/2025

Join our interactive live Meet the Expert Session: "CaReMe Syndrome: Early Recognition and Diagnoses"
📅 Wednesday, 15th October |🕐10:00 AM CEST
🎤 Speakers: Prof. Vlado Perkovic, Prof. Rudolf de Boer, and Prof. Avraham Karasik

Put your clinical questions at the forefront! This is your opportunity to engage directly with top experts, get evidence-based answers to diagnostic challenges, and discuss strategies you can apply in daily practice.

💡Submit your clinical questions on syndrome in advance, and our experts will prepare tailored, evidence-based responses: https://www.surveymonkey.com/r/G8Y7C5P
🔗Find out more: https://unlok-education.com/meet-the-expert-session-careme-syndrome-early-recognition-and-diagnosis/

Join us for a one-hour interactive webinar:"Obesity Management is a Long Journey: Chances and Challenges"📅Wednesday, 8th...
08/10/2025

Join us for a one-hour interactive webinar:"Obesity Management is a Long Journey: Chances and Challenges"
📅Wednesday, 8th October |🕐4:00 PM CEST
🎤 Speakers: Dr. Gabriel Cuatrecasas, Dr. Luca Busetto, and Prof. Shlomo Vinker

Led by Prof. Shlomo Vinker, this session will provide practical, evidence-based insights to support diagnosis, individualized treatment planning, and ongoing care for patients living with obesity. Through expert talks and live Q&A, you’ll gain tools to navigate obesity as a chronic, relapsing condition—beyond BMI and into real-life clinical practice.
🔗 Register now: https://us02web.zoom.us/webinar/register/WN_XMKyHjcmRhSeFG6DHTLFhA #/registration

📢 TOMORROW! Join the launch of the UNLOKall Journal Club, discussing:"Strategies to Improve Therapeutic Compliance of Ca...
17/09/2025

📢 TOMORROW! Join the launch of the UNLOKall Journal Club, discussing:
"Strategies to Improve Therapeutic Compliance of CaReMeLO Patients."
Moderator: Dr. Ana Cebrian
Speaker: Dr. Justyna Tymińska

Discover practical ways to enhance treatment adherence in people with cardiometabolic, renal, and obesity-related conditions.

📅 Date: Thursday, 18 September 2025
🕓 Time: 16:00 CEST
👉 REGISTER NOW: https://us02web.zoom.us/webinar/register/8017493748061/WN_Y6oJzikQSG6P10kEHYoexg

In just 45 minutes, you will learn:
🔹How to identify and overcome patient beliefs & barriers
🔹Practical tips to simplify complex treatment plans
🔹The role of digital tools in boosting engagement
🔹Real-world strategies for lasting impact

Let’s shape better care together—don’t miss this opportunity to learn, share, and connect!

📰 Lifestyle changes and vaccination could prevent most liver cancer cases’ “Three in five liver cancer cases globally co...
29/08/2025

📰 Lifestyle changes and vaccination could prevent most liver cancer cases’

“Three in five liver cancer cases globally could be prevented by reducing obesity and alcohol consumption and increasing uptake of the hepatitis vaccine, a study has found.
The Lancet Commission on liver cancer found that most cases were preventable if alcohol consumption, fatty liver disease, and levels of viral B and C were reduced.” 🔗 Continue reading:

Lancet Commission says three in five cases preventable with action on obesity, alcohol and hepatitis

⏳ Final week to access the   platform! If you haven’t explored the sessions yet, now’s the time to log in and take full ...
25/08/2025

⏳ Final week to access the platform!

If you haven’t explored the sessions yet, now’s the time to log in and take full advantage of the expert insights, research breakthroughs, and clinical strategies available on demand. 🩺Access closes on August 31, 2025 — don’t miss your chance to learn from global leaders in cardiovascular, renal, metabolic, liver, and obesity care:💻 https://caremelo.kenes.com/virtual-login/

📰Millions in West do not know they have aggressive fatty liver disease, study says “More than 15 million people in the U...
18/08/2025

📰Millions in West do not know they have aggressive fatty liver disease, study says

“More than 15 million people in the US, UK, Germany , and France do not know they have the most aggressive form of fatty liver disease, according to research.
Metabolic dysfunction-associated steatotic (MASLD) – the formal name for non-alcoholic disease – occurs in people who drink no or minimal amounts of alcohol, whose liver contains more than 5% fat.” 🔗Continue reading: https://www.theguardian.com/society/2025/jun/05/millions-in-west-do-not-know-they-have-aggressive-fatty-liver-disease-study-says

Research finds more than 15m in US, UK, Germany and France with MASH have not been diagnosed

📬 Want to stay ahead of the curve in  , renal,  , liver, and obesity care? Subscribe to our newsletter and be the first ...
11/08/2025

📬 Want to stay ahead of the curve in , renal, , liver, and obesity care?
Subscribe to our newsletter and be the first to know about upcoming events, expert insights, research highlights, and exclusive updates from the community!👉 Sign up here: https://caremelo.kenes.com/

Тhe   platform is still open, and it's your gateway to world-class insights in cardiovascular, renal, metabolic, liver, ...
04/08/2025

Тhe platform is still open, and it's your gateway to world-class insights in cardiovascular, renal, metabolic, liver, and obesity care!

On-demand access is available until 📆 August 31, 2025 — don’t miss this chance to engage with the full scientific program. 💻 Start watching now: https://caremelo.kenes.com/virtual-login/

We were thrilled to welcome over 1,000 participants, both in   and online, to the 2nd Cardiovascular, Renal, Metabolic, ...
15/07/2025

We were thrilled to welcome over 1,000 participants, both in and online, to the 2nd Cardiovascular, Renal, Metabolic, Liver, and Obesity Conference! 🤩

The event may have wrapped up, but the learning doesn’t stop here. If you couldn’t join us live, don’t worry – here's your chance to catch up!💻Dive into the latest research and expert discussions at your convenience before August 31, 2025: https://caremelo.kenes.com/virtual-login/

Adres

Warsaw

Strona Internetowa

Ostrzeżenia

Bądź na bieżąco i daj nam wysłać e-mail, gdy Cardiovascular, Renal, Metabolic, Liver and Obesity Conference umieści wiadomości i promocje. Twój adres e-mail nie zostanie wykorzystany do żadnego innego celu i możesz zrezygnować z subskrypcji w dowolnym momencie.

Udostępnij

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram